These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Corp ES; McQuade J; Moran TH; Smith GP Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086 [TBL] [Abstract][Full Text] [Related]
7. Involvement of brain CCK in the adaptation of gut motility to digestive status and stress: a review. Buéno L J Physiol Paris; 1993; 87(5):301-6. PubMed ID: 8298607 [TBL] [Abstract][Full Text] [Related]
8. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle. Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733 [TBL] [Abstract][Full Text] [Related]
9. [Cholecystokinin and its antagonists: effects on digestive motility]. Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015 [No Abstract] [Full Text] [Related]
10. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. Scarpignato C; Pelosini I Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210 [TBL] [Abstract][Full Text] [Related]
11. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat. Rodríguez-Membrilla A; Martínez V; Vergara P J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590 [TBL] [Abstract][Full Text] [Related]
12. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. Katschinski M; Schirra J; Begliner C; Langbein S; Wank U; D'Amato M; Arnold R Eur J Clin Invest; 1996 Jul; 26(7):574-83. PubMed ID: 8864420 [TBL] [Abstract][Full Text] [Related]
13. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. O'Neill MF; Dourish CT; Iversen SD Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197 [TBL] [Abstract][Full Text] [Related]
14. CCK1 antagonists: are they ready for clinical use? Peter SA; D'Amato M; Beglinger C Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic and chemical developments of cholecystokinin receptor ligands. de Tullio P; Delarge J; Pirotte B Expert Opin Investig Drugs; 2000 Jan; 9(1):129-46. PubMed ID: 11060666 [TBL] [Abstract][Full Text] [Related]
17. [Cholecystokinin receptors involved in the central and peripheral nervous control mechanisms in gastric acid secretion]. Watanabe K; Yano S; Mitani H Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):153-62. PubMed ID: 7959408 [TBL] [Abstract][Full Text] [Related]
18. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons. Rasmussen K Ann N Y Acad Sci; 1994 Mar; 713():300-11. PubMed ID: 8185172 [No Abstract] [Full Text] [Related]
19. A possible interaction between serotonin and cholecystokinin-8 in the ileo-colonic motor responses to feeding in rats. Benouali-Pellissier S; Roger T; Roche M Scand J Gastroenterol; 1994 Feb; 29(2):138-43. PubMed ID: 8171281 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists). de Tullio P; Delarge J; Pirotte B Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]